Racotumomab (Vaxira)

This drug is currently approved in Argentina and Cuba.

Mechanism of action

From Wikipedia: Racotumomab is an anti-idiotypic mouse monoclonal antibody that mimics NGc gangliosides, thus triggering an immune response against the tumor antigen NGcGM3. Therefore, rather than being a passive antibody therapy, Racotumomab acts as a therapeutic vaccine.

Diseases for which it is used

• Non-small cell lung cancer

Also known as

• Brand name: Vaxira